Published in Pharmacogenet Genomics on May 01, 2012
PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet Genomics (2013) 0.89
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
The effects of human population structure on large genetic association studies. Nat Genet (2004) 14.88
Large-scale genotyping of complex DNA. Nat Biotechnol (2003) 10.00
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet (2003) 5.82
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet (2009) 3.83
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med (2013) 3.46
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J (2007) 3.32
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2002) 3.25
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet (2002) 2.90
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation (2013) 2.90
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol (2006) 2.68
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol (2007) 2.50
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds. Circulation (2011) 2.36
Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med (2013) 2.31
Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg (2007) 2.24
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure. Clin Pharmacol Ther (2005) 2.20
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation (2003) 2.16
Postinfarction ventricular septal defects: towards a new treatment algorithm? Ann Thorac Surg (2009) 2.14
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med (2006) 2.13
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. Int J Cardiol (2007) 2.05
A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med (2010) 2.00
Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol Heart Circ Physiol (2002) 2.00
Risk of hepatitis C virus exposure in orthopedic surgery: is universal screening needed? Am J Orthop (Belle Mead NJ) (2014) 1.99
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78
Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation (2010) 1.73
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation (2010) 1.72
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. J Am Coll Cardiol (2004) 1.72
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol (2007) 1.70
Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation (2003) 1.69
Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet (2008) 1.66
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging (2009) 1.63
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol (2011) 1.62
Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. J Thorac Cardiovasc Surg (2010) 1.60
Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med (2009) 1.57
Temporary coronary artery occlusion during off-pump coronary artery bypass grafting with the new poloxamer P407 does not cause endothelial dysfunction in epicardial coronary arteries. J Thorac Cardiovasc Surg (2006) 1.57
Statin in combination with β-blocker therapy reduces postoperative stroke after coronary artery bypass graft surgery. Ann Thorac Surg (2011) 1.56
Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail (2010) 1.55
The genetics of congenital amusia (tone deafness): a family-aggregation study. Am J Hum Genet (2007) 1.54
Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: first in man experience with a temporary implant. Catheter Cardiovasc Interv (2007) 1.53
Effect of pericardial blood processing on postoperative inflammation and the complement pathways. Ann Thorac Surg (2008) 1.53
Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties. Cardiovasc Res (2008) 1.51
The pharmacokinetics of ezetimibe. Can J Clin Pharmacol (2003) 1.51
Late iatrogenic coronary stenosis after selective intraoperative antegrade myocardial protection for stentless aortic valve replacement. J Thorac Cardiovasc Surg (2006) 1.48
Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial. Circ Heart Fail (2012) 1.48
Carpentier-Edwards pericardial valve in the aortic position: 25-years experience. Ann Thorac Surg (2013) 1.47
Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc Interv (2007) 1.45
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol (2012) 1.44
Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure. Eur Heart J (2003) 1.44
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. J Thorac Cardiovasc Surg (2007) 1.44
Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy. PLoS One (2007) 1.42
Acute heart failure: perspectives from a randomized trial and a simultaneous registry. Circ Heart Fail (2012) 1.42
Conversion to sinus rhythm does not improve long-term survival after valve surgery: insights from a 20-year follow-up study. Eur J Cardiothorac Surg (2005) 1.42
Challenge of informing patient decision making: what can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-of-life issues? Circ Cardiovasc Qual Outcomes (2014) 1.41
Mutations in DCC cause congenital mirror movements. Science (2010) 1.41
Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients. Ann Thorac Surg (2006) 1.39
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. J Am Coll Cardiol (2003) 1.39
Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trial. Can J Cardiol (2011) 1.37
Myocyte growth, repair, and oxidative stress following pediatric heart transplantation. Pediatr Transplant (2014) 1.37
Rare copy number variants contribute to congenital left-sided heart disease. PLoS Genet (2012) 1.35
Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Crit Care Med (2007) 1.35
A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study. Eur Heart J (2009) 1.34
Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail (2008) 1.32
Repair of aortic false aneurysm using deep hypothermia and circulatory arrest. Ann Thorac Surg (2004) 1.31
Endovascular management of pseudo-aneurysms after previous surgical repair of congenital aortic coarctation. Eur J Cardiothorac Surg (2007) 1.30
No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans. J Clin Invest (2008) 1.30
Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension (2007) 1.29
Cardiac masses: an integrative approach using echocardiography and other imaging modalities. Heart (2011) 1.29
Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors. Mech Ageing Dev (2007) 1.28
High-density single-nucleotide polymorphism maps of the human genome. Genomics (2005) 1.27
Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ (2003) 1.25
Human monogenic disorders - a source of novel drug targets. Nat Rev Genet (2006) 1.24
A propensity-matched study of elevated jugular venous pressure and outcomes in chronic heart failure. Am J Cardiol (2009) 1.24
Prevalence of and risk factors for persistent postoperative nonanginal pain after cardiac surgery: a 2-year prospective multicentre study. CMAJ (2014) 1.23
Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction. J Mol Cell Cardiol (2003) 1.23
Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. CMAJ (2005) 1.23